Cited by 44Forensic Toxicology and Drug AnalysisOpioid Use Disorder TreatmentAlkaloids: synthesis and pharmacology

First identification, chemical analysis and pharmacological characterization of N-piperidinyl etonitazene (etonitazepipne), a recent addition to the 2-benzylbenzimidazole opioid subclass

Open access
Vandeputte, Marthe M., Verougstraete, Nick, Walther, Donna, Glatfelter, Grant C., Malfliet, Jeroen, Baumann, Michael H., Verstraete, Alain G., Stove, Christophe P.·2022·Archives of Toxicology

Abstract

N-Piperidinyl etonitazene ('etonitazepipne') represents a recent addition to the rapidly expanding class of 2-benzylbenzimidazole 'nitazene' opioids. Following its first identification in an online-sourced powder and in biological samples from a patient seeking help for detoxification, this report details its in-depth chemical analysis and pharmacological characterization. Analysis of the powder via different techniques (LC-HRMS, GC-MS, UHPLC-DAD, FT-IR) led to the unequivocal identification of N-piperidinyl etonitazene. Furthermore, we report the first activity-based detection and analytical identification of N-piperidinyl etonitazene in authentic samples. LC-HRMS analysis revealed concentrations of 1.21 ng/mL in serum and 0.51 ng/mL in urine, whereas molecular networking enabled the tentative identification of various (potentially active) urinary metabolites. In addition, we determined that the extent of opioid activity present in the patient's serum was equivalent to the in vitro opioid activity exerted by 2.5-10 ng/mL fentanyl or 10-25 ng/mL hydromorphone in serum. Radioligand binding assays in rat brain tissue revealed that the drug binds with high affinity (K i = 14.3 nM) to the µ-opioid receptor (MOR). Using a MOR-β-arrestin2 activation assay, we found that N-piperidinyl etonitazene is highly potent (EC 50 = 2.49 nM) and efficacious (E max = 183% versus hydromorphone) in vitro. Pharmacodynamic evaluation in male Sprague Dawley rats showed that N-piperidinyl etonitazene induces opioid-like antinociceptive, cataleptic, and thermic effects, its potency in the hot plate assay (ED 50 = 0.0205 mg/kg) being comparable to that of fentanyl (ED 50 = 0.0209 mg/kg), and > 190 times higher than that of morphine (ED 50 = 3.940 mg/kg). Taken together, our findings indicate that N-piperidinyl etonitazene is a potent opioid with the potential to cause harm in users.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00204-022-03294-2

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Some nitazene analogs are more potent than fentanyl.

    “Importantly, some analytes included in the nitazene class are reported to be more potent than fentanyl, posing a greater risk to drug users while potentially increasing analytical challenges in the laboratory, particularly for screening due to the need for low limits of detection [14][15][16][17][18].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 38 · Cited by 44

Research works printed but not linked: 34

  1. Adler MW, Geller EB, Rosow CE, Cochin J (1988) The Opioid System and Temperature Regulation. Annu Rev Pharmacol Toxicol 28: 429– 449. 10.1146/annurev.pa.28.040188.002241 2837979 · DOI
  2. Baumann MH, Kopajtic TA, Madras BK (2018) Pharmacological Research as a Key Component in Mitigating the Opioid Overdose Crisis. Trends in Pharmacological Sciences 39: 995– 998. 10.1016/j.tips.2018.09.006 30454770 · DOI
  3. Bergh MS-S, Bogen IL, Garibay N, Baumann MH (2021) Pharmacokinetics and pharmacodynamics of cyclopropylfentanyl in male rats. Psychopharmacology 238: 3629– 3641. 10.1007/s00213-021-05981-x 34613431 PMC8629808 · DOI
  4. Brandenberger H (1974) Die Rolle des Massenspektrometers im toxikologisch-chemischen Laboratorium. Deutsche Lebensmittel-Rundschau 70(1): 31– 39
  5. Bromig G (1958) Über neue starkwirkende Analgetika und ihre klinische Erprobung. Klinische Wochenschrift 36: 960– 963. 10.1007/BF01486702 13612082 · DOI · Paper page
  6. Cannaert A, Deventer M, Fogarty M, (2019) Hide and Seek: Overcoming the Masking Effect of Opioid Antagonists in Activity-Based Screening Tests. Clinical Chemistry 65: 1604– 1605. 10.1373/clinchem.2019.309443 31575612 · DOI
  7. Cannaert A, Ramírez Fernández M del M, Theunissen EL, (2020) Semiquantitative Activity-Based Detection of JWH-018, a Synthetic Cannabinoid Receptor Agonist, in Oral Fluid after Vaping. Anal Chem 92: 6065– 6071. 10.1021/acs.analchem.0c00484 32200637 · DOI
  8. Cannaert A, Vasudevan L, Friscia M, (2018) Activity-based concept to screen biological matrices for opiates and (synthetic) opioids. Clinical Chemistry 64: 1221– 1229. 10.1373/clinchem.2018.289496 29776952 · DOI
  9. Ciccarone D (2019) The triple wave epidemic: Supply and demand drivers of the US opioid overdose crisis. International Journal of Drug Policy 71: 183– 188. 10.1016/j.drugpo.2019.01.010 30718120 PMC6675668 · DOI · Paper page
  10. Geller EB, Hawk C, Keinath SH, (1983) Subclasses of opioids based on body temperature change in rats: Acute subcutaneous administration. Journal of Pharmacology and Experimental Therapeutics 225: 391– 398 6842402
  11. Grigoryev A, Kavanagh P, Dowling G, Rodin I (2022) Tentative Identification of Etazene (etodesnitazene) Metabolites in Rat Serum and Urine by Gas Chromatography-Mass Spectrometry and Accurate Mass Liquid Chromatography-Mass Spectrometry. Journal of Analytical Toxicology bkac001. 10.1093/jat/bkac001 34994784 · DOI
  12. Gross F, Turrian H (1957) Über Benzimidazolderivate mit starker analgetischer Wirkung. Experientia 13: 401– 403. 10.1007/BF02161117 13473818 · DOI
  13. Hunger A, Kebrle J, Rossi A, Hoffmann K (1957) Synthese basisch substituierter, analgetisch wirksamer Benzimidazol-Derivate. Experientia 13: 400– 401. 10.1007/BF02161116 13473817 · DOI
  14. Hunger A, Kebrle J, Rossi A, Hoffmann K (1960a) Benzimidazol-Derivate und verwandte Heterocyclen II. Synthese von 1-Aminoalkyl-2-benzyl-benzimidazolen. Helvetica Chimica Acta 43: 800– 809. 10.1002/hlca.19600430323 · DOI
  15. Hunger A, Kebrle J, Rossi A, Hoffmann K (1960b) Benzimidazol-Derivate und verwandte Heterocyclen III. Synthese von 1-Aminoalkyl-2-benzyl-nitro-benzimidazolen. Helvetica Chimica Acta 43: 1032– 1046. 10.1002/hlca.19600430412 · DOI
  16. Hunger A, Kebrle J, Rossi A, Hoffmann K (1960c) Benzimidazol-Derivate und verwandte Heterocyclen VI. Synthese von Phenyl-[1-aminoalkyl-benzimidazolyl-(2)]-essigsäure-estern und -amiden. Helvetica Chimica Acta 43: 1727– 1733. 10.1002/hlca.19600430634 · DOI
  17. Krotulski AJ, Manini A, Calello D, (2021a) N-piperidinyl etonitazene. https://www.npsdiscovery.org/wp-content/uploads/2021/11/N-Piperidinyl-Etonitazene_112221_ToxicologyAnalyticalReport.pdf?mc_cid=09d08f4c2f&mc_eid=UNIQID PMC9815205 35708103
  18. Krotulski AJ, Papsun DM, Kacinko SL, Logan BK (2020) Isotonitazene Quantitation and Metabolite Discovery in Authentic Forensic Casework. Journal of Analytical Toxicology 44: 521– 530. 10.1093/jat/bkaa016 32091095 · DOI · Paper page
  19. Mardal M, Andreasen MF, Mollerup CB, (2019) HighResNPS.com: An Online Crowd-Sourced HR-MS Database for Suspect and Non-targeted Screening of New Psychoactive Substances. Journal of Analytical Toxicology 43: 520– 527. 10.1093/jat/bkz030 31095696 · DOI
  20. Nothias L-F, Petras D, Schmid R, (2020) Feature-based molecular networking in the GNPS analysis environment. Nat Methods 17: 905– 908. 10.1038/s41592-020-0933-6 32839597 PMC7885687 · DOI
  21. Ortiz de Montellano PR, Nelson SD (2011) Rearrangement reactions catalyzed by cytochrome P450s. Archives of Biochemistry and Biophysics 507: 95– 110. 10.1016/j.abb.2010.10.016 20971058 PMC3039701 · DOI
  22. Pluskal T, Castillo S, Villar-Briones A, Orešič M (2010) MZmine 2: Modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. BMC Bioinformatics 11: 395. 10.1186/1471-2105-11-395 20650010 PMC2918584 · DOI
  23. Pottie E, Tosh DK, Gao Z-G, (2020) Assessment of biased agonism at the A3 adenosine receptor using β-arrestin and miniGαi recruitment assays. Biochemical Pharmacology 177: 113934. 10.1016/j.bcp.2020.113934 32224136 PMC7382964 · DOI
  24. Pöyhiä R, Kalso EA (1992) Antinociceptive Effects and Central Nervous System Depression Caused by Oxycodone and Morphine in Rats. Pharmacology & Toxicology 70: 125– 130. 10.1111/j.1600-0773.1992.tb00441.x 1508838 · DOI
  25. Rawls SM, Benamar K (2011) Effects of opioids cannabinoids and vanilloids on body temperature. Front Biosci S3: 822– 845. 10.2741/s190 PMC3979758 21622235 · DOI
  26. Sharma KK, Hales TG, Rao VJ, (2019) The search for the “next” euphoric non-fentanil novel synthetic opioids on the illicit drugs market: current status and horizon scanning. Forensic Toxicol 37: 1– 16. 10.1007/s11419-018-0454-5 30636980 PMC6314991 · DOI
  27. Sorokin VI (1999) Illegal synthesis of etonitazene. Journal of the Clandestine Laboratory Investigating Chemists Association 9: 20
  28. Taracha E, Mierzejewski P, Lehner M, (2009) Stress-opioid interactions: a comparison of morphine and methadone. Pharmacological Reports 61: 424– 435. 10.1016/S1734-1140(09)70083-0 19605941 · DOI
  29. Truver MT, Smith CR, Garibay N, (2020) Pharmacodynamics and pharmacokinetics of the novel synthetic opioid, U-47700, in male rats. Neuropharmacology 177: 108195. 10.1016/j.neuropharm.2020.108195 32533977 PMC7554234 · DOI
  30. Vandeputte MM, Krotulski AJ, Papsun DM, (2021a) The rise and fall of isotonitazene and brorphine: two recent stars in the synthetic opioid firmament. Journal of Analytical Toxicology bkab082. 10.1093/jat/bkab082 34233349 · DOI · Paper page
  31. Verougstraete N, Vandeputte MM, Lyphout C, (2020) First report on brorphine: the next opioid on the deadly new psychoactive substances’ horizon? Journal of Analytical Toxicology 44: 937– 946. 10.1093/jat/bkaa094 32744605 · DOI · Paper page
  32. Walton SE, Krotulski AJ, Logan BK (2021) A Forward-Thinking Approach to Addressing the New Synthetic Opioid 2-Benzylbenzimidazole Nitazene Analogs by Liquid Chromatography–Tandem Quadrupole Mass Spectrometry (LC–QQQ-MS). Journal of Analytical Toxicology bkab117. 10.1093/jat/bkab117 PMC8935987 34792157 · DOI · Paper page
  33. Wang M, Carver JJ, Phelan VV, (2016) Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking. Nat Biotechnol 34: 828– 837. 10.1038/nbt.3597 27504778 PMC5321674 · DOI · Paper page
  34. Wong B, Perkins MW, Tressler J, (2017) Effects of inhaled aerosolized carfentanil on real-time physiological responses in mice: a preliminary evaluation of naloxone. Inhalation Toxicology 29: 65– 74. 10.1080/08958378.2017.1282065 28330429 · DOI

Authors
Vandeputte, M. M., Verougstraete, N., Walther, D., Glatfelter, G. C., Malfliet, J., Baumann, M. H., Verstraete, A. G., & Stove, C. P.
Affiliations
  • Ghent University (BE)
  • Ghent University Hospital (BE)
  • National Institutes of Health (US)
Corresponding author
Stove, Christophe P.
Venue
Archives of Toxicology
Published
2022-04-21
Volume
96
Issue
6
Pages
1865-1880
ISSN
  • 0340-5761 (ISSN-L)
  • 1432-0738
OpenAlex
W4224302202
Cited by
44
References
38
Citations by year
2026: 7 · 2025: 12 · 2024: 15 · 2023: 6 · 2022: 4
FWCI
6.17
Type
journal article
Language
en
Open access
Locations
  • Archives of Toxicology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion)
  • Ghent University Academic Bibliography (Ghent University) (submittedVersion, other-oa)
Funders
  • Fonds Wetenschappelijk Onderzoek (1S81522N, 1703320N, G069419N)
  • Bijzonder Onderzoeksfonds (01J15517)
  • National Institute on Drug Abuse
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Alkaloids: synthesis and pharmacology
Keywords
opioid pharmacology, antinociception, catalepsy, urinary metabolites, molecular networking
MeSH terms
Analgesics, Opioid, Animals, Benzimidazoles, Hydromorphone, Fentanyl, Humans, Male, Powders, Rats, Sprague-Dawley, Spectroscopy, Fourier Transform Infrared, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review